Table-II.
Groups | Case | FEV1% | FVC(L) | PEF% | ||||||
---|---|---|---|---|---|---|---|---|---|---|
4th week | 8th week | 12th week | 4th week | 8th week | 12th week | 4th week | 8th week | 12th week | ||
Control | 38 | 73.91±5.66 ▲ |
82.34±5.02 ▲ |
87.53±5.76 ▲ |
1.63±0.47 ▲ |
1.70±0.51 ▲ |
1.80±0.59 ▲ |
77.39±3.56 ▲ |
81.63±4.76 ▲ |
86.35±3.65 ▲ |
Treatment | 38 | 79.56±7.01 ▲# |
87.44±6.74 ▲# |
91.61±5.73 ▲* |
1.87±0.42 ▲* |
1.95±0.48 ▲* |
2.42±0.55 ▲# |
80.0±3.68 ▲# |
85.52±3.9 ▲# |
89.67±4.14 ▲# |
vs before the treatment P < 0.01;
vs. control group P < 0.05,
P < 0.01